Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
NCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 02821013 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04720768 Brief Summary This is an open-label, phase IB, non-randomised study…
Read more arrow_forwardNCT 06554795 Brief Summary A Phase 1/2a First-in-Human Study of DB-1419 in…
Read more arrow_forwardNCT 06824155 Brief Summary This is a first-in-human, Phase 0/1, open-label study…
Read more arrow_forwardNCT 06349408 Brief Summary This is a Phase 1 multicenter, multi-regional, open-label,…
Read more arrow_forwardNCT 06112314 Brief Summary This is a phase 3, randomized, controlled study…
Read more arrow_forwardNCT 03486873 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 02645149 Brief Summary This is a patient oriented translational research project…
Read more arrow_forward